ST. LOUIS, July 31, 2018 (GLOBE NEWSWIRE) — Stereotaxis, Inc. (OTCQX:STXS), the global leader in innovative robotic technologies for the treatment of cardiac arrhythmias, today announced that it will release financial results for its 2018 second quarter ended June 30, 2018 on Tuesday, August 7, 2018 before the open of […]
Financial
VitalHub Announces Sale of B Care to support Osler’s Cardiac Care Program
TORONTO, July 31, 2018 (GLOBE NEWSWIRE) — VitalHub Corp. (the “Company” or “VitalHub”) (TSXV:VHI) is pleased to announce the sale of the B Care Electronic Health Record (“EHR”) to support William Osler Health System’s (“Osler”) Cardiac Care Program. This sale follows a successful response to a Request for Proposal issued […]
InspireMD Schedules Second Quarter 2018 Earnings Conference Call
Tel Aviv, July 31, 2018 (GLOBE NEWSWIRE) — InspireMD, Inc. (NYSE: NSPR), developer of the CGuard™ Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that it will host a conference call on Tuesday, August 7th at 8:00 a.m. Eastern […]
Semler Reports Second Quarter and First Half 2018 Financial Results
SAN JOSE, Calif., July 31, 2018 /PRNewswire/ — Semler Scientific, Inc. (OTCQB: SMLR), an emerging growth company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today reported financial results for the three and six months ended June 30, 2018. “We believe that the achievement of healthier clinical outcomes […]
CARMAT Appoints Thierry Dupoux, Previously Worldwide Vice President of Quality Assurance at LivaNova, as Senior Director of Quality Assurance
PARIS–(BUSINESS WIRE)–Regulatory News: CARMAT (Paris:ALCAR) (FR0010907956, ALCAR), the designer and developer of the world’s most advanced total artificial heart project, aiming to provide a therapeutic alternative for people suffering from end-stage biventricular heart failure, today announced the appointment of Thierry Dupoux as Senior Director of Quality Assurance. Thierry Dupoux is […]
Tenaya Therapeutics Appoints Faraz Ali as Chief Executive Officer
SOUTH SAN FRANCISCO, Calif., July 30, 2018 /PRNewswire/ — Tenaya Therapeutics, a preclinical-stage biotechnology company focused on discovery and development of novel therapies for heart failure, announced the appointment of Faraz Ali as Chief Executive Officer. “We are thrilled to bring Faraz on board as the new CEO,” said David Goeddel, Ph.D., Managing Partner at The […]
TransMed7, LLC Announces Appointment of Dr. John Simpson as Strategic Advisor to Its Board of Directors
PORTOLA VALLEY, Calif.–(BUSINESS WIRE)–TransMed7, LLC is delighted to announce the appointment of John B. Simpson, Ph.D., M.D., as Strategic Advisor to the TransMed7 Board of Directors. “Dr. Simpson’s remarkable history of clinical excellence, innovation, scientific achievement, and entrepreneurial expertise immediately expands TransMed7’s strategic options for rapid development and deployment of […]
LeMaitre Q2 2018 Record Sales $27.0mm (+5%), Record EPS $0.43 (+86%)
BURLINGTON, Mass., July 26, 2018 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2018 results, provided guidance and announced a $0.07/share dividend. Q2 2018 Results Record sales of $27.0mm, +5% vs. Q2 2017 Record operating income of $11.5mm vs. $5.5mm, +108% Record net income […]
Zynex Schedules 2018 Second Quarter Earnings Release and Webcast
LONE TREE, Colo., July 27, 2018 /PRNewswire/ — Zynex (OTCQB: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, announced today that it will host the Company’s 2018 second quarter investor webcast on Thursday, August 2, 2018 at 11:00 […]
Edwards Lifesciences Reports Second Quarter Results
IRVINE, Calif., July 26, 2018 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2018. Second Quarter and Recent Highlights: Sales grew 12 percent; underlying1 sales grew 10 percent Global THVT sales grew […]
Recent
AVS Announces Positive Safety and Effectiveness Data in First 95 Patients Treated in Pulse IVL IDE Study
Dallas Cardiology Group Expands Access to Advanced Cardiac Imaging in North Texas Following High Patient Demand
New Data Show Viz.ai’s AI-Enabled ECG Screening Increases Detection and Accelerates Diagnosis of Hypertrophic Cardiomyopathy
Popular
- No commented posts yet